DNP - Der Neurologe und Psychiater

, Volume 14, Issue 9, pp 47–56 | Cite as

Eine umfassende Differenzialdiagnose ist entscheidend

Myelitis
Fortbildung
First Online:

Zusammenfassung

Eine Myelitis hat meist entzündliche oder infektiöse Ursachen. Allerdings ist eine Abgrenzung gegenüber kompressiven sowie traumatischen, vaskulären oder metabolischen Auslösern und selten auch gegenüber primär glialer Tumoren oder einer neoplastischen Infiltration erforderlich. Die Differenzialdiagnostik sollte daher neben Anamnese und klinische Untersuchung eine Bildgebung sowie labor- und liquorchemische Untersuchungen beinhalten.

This is a preview of subscription content, log in to check access.

Literatur

  1. 1.
    Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, et al. Longitudinal extensive transverse myelitis-it’s not all neuromyelitis optica. Nat Rev Neurol 2011 Dec;7(12):688–698.PubMedCrossRefGoogle Scholar
  2. 2.
    Sellner J, Luthi N, Buhler R, Gebhardt A, Findling O, Greeve I, et al. Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis. Eur J Neurol 2008 Apr;15(4):398–405.PubMedCrossRefGoogle Scholar
  3. 3.
    Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002 Aug 27;59(4):499–505.Google Scholar
  4. 4.
    Perumal J, Zabad R, Caon C, MacKenzie M, Tselis A, Bao F, et al. Acute transverse myelitis with normal brain MRI: long-term risk of MS. J Neurol 2008 Jan;255(1):89–93.PubMedCrossRefGoogle Scholar
  5. 5.
    Agmon-Levin N, Kivity S, Szyper-Kravitz M, Shoenfeld Y. Transverse myelitis and vaccines: a multi-analysis. Lupus 2009 Nov;18(13):1198–1204.PubMedCrossRefGoogle Scholar
  6. 6.
    Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist 2007 Jan;13(1):2–11.PubMedCrossRefGoogle Scholar
  7. 7.
    Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006 Mar;59(3):566–569.PubMedCrossRefGoogle Scholar
  8. 8.
    Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology 2007 Apr 17;68(16 Suppl 2):S23–S36.PubMedCrossRefGoogle Scholar
  9. 9.
    Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000 Feb;59(2):120–124.PubMedCrossRefGoogle Scholar
  10. 10.
    D’Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 2004 Feb;31(2):280–285.PubMedGoogle Scholar
  11. 11.
    Fox RI. Sjogren’s syndrome. Lancet 2005 Jul 23;366(9482):321–331.PubMedCrossRefGoogle Scholar
  12. 12.
    Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, et al. Clinical manifestations of neurological involvement in primary Sjogren’s syndrome. Clin Rheumatol 2011 Apr;30(4):485–490.PubMedCrossRefGoogle Scholar
  13. 13.
    Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977 Sep;87(3):336–345.PubMedCrossRefGoogle Scholar
  14. 14.
    Bolat S, Berding G, Dengler R, Stangel M, Trebst C. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J Neurol Sci 2009 Dec 15;287(1-2):257–259.PubMedCrossRefGoogle Scholar
  15. 15.
    Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 1990 May 5;335(8697):1078–1080.Google Scholar
  16. 16.
    Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behcet’s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999 Nov;122:2171–2182.PubMedCrossRefGoogle Scholar
  17. 17.
    Cho TA, Vaitkevicius H. Infectious myelopathies. Continuum (Minneap Minn) 2012 Dec;18(6 Infectious Disease):1351–1373.Google Scholar
  18. 18.
    Ferrari TC, Moreira PR. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol 2011 Sep;10(9):853–864.PubMedCrossRefGoogle Scholar
  19. 19.
    Ducray F, Roos-Weil R, Garcia PY, Slesari J, Heinzlef O, Chatelain D, et al. Devic’s syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2007 Mar;78(3):325–327.PubMedCrossRefGoogle Scholar
  20. 20.
    Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004 Aug;75(8):1135–1140.PubMedCrossRefGoogle Scholar
  21. 21.
    Rogers LR. Neurologic complications of radiation. Continuum (Minneap Minn ) 2012 Apr;18(2):343–354.Google Scholar
  22. 22.
    Mull M, Nijenhuis RJ, Backes WH, Krings T, Wilmink JT, Thron A. Value and limitations of contrast-enhanced MR angiography in spinal arteriovenous malformations and dural arteriovenous fistulas. AJNR Am J Neuroradiol 2007 Aug;28(7):1249–1258.PubMedCrossRefGoogle Scholar
  23. 23.
    Toossi S, Josephson SA, Hetts SW, Chin CT, Kralik S, Jun P, et al. Utility of MRI in spinal arteriovenous fistula. Neurology 2012 Jul 3;79(1):25–30.PubMedCrossRefGoogle Scholar
  24. 24.
    Misra UK, Kalita J, Das A. Vitamin B12 deficiency neurological syndromes: a clinical, MRI and electrodiagnostic study. Electromyogr Clin Neurophysiol 2003 Jan;43(1):57–64.PubMedGoogle Scholar
  25. 25.
    Goodman BP, Chong BW, Patel AC, Fletcher GP, Smith BE. Copper deficiency myeloneuropathy resembling B12 deficiency: partial resolution of MR imaging findings with copper supplementation. AJNR Am J Neuroradiol 2006 Nov;27(10):2112–2114.PubMedGoogle Scholar
  26. 26.
    Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, et al. Pattern of demyelination occurring during anti-TNF-alpha therapy: a French national survey. Rheumatology (Oxford) 2013 Jan 3.Google Scholar

Copyright information

© Urban & Vogel 2013

Authors and Affiliations

  1. 1.HannoverDeutschland
  2. 2.HannoverDeutschland
  3. 3.Institut für Diagnostische und interventionelle Neuroradiologie, Medizinische HochschuleHannoverDeutschland

Personalised recommendations